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INTRODUCTION 
 
With the rapid rate of socio-economic development and socio-cultural 
changes, changes in dietary pattern and changes in lifestyle, increasing BMI has 
become a healthcare burden to the nation. This increasing rates of BMI have 
affected all age groups universally.it causes major medical ailments like 
hypertension, Diabetes, cardiovascular, neurovascular diseases, arthritis and 
causes a lot of morbidity and mortality.  
Increasing BMI in women poses multiple threat of illness especially in the 
reproductive age group impacting pregnancy. Pregnant women with overweight 
and obesity are at a higher risk of developing complications at all stages of the 
physiological pregnancy, be it antepartum, intrapartum, post partum, causing an 
economic burden on the healthcare department. The babies born to these mothers 
also exhibit multiple neonatal complications. Hence it is required a focus on the 
methods to prevent this trend of increasing weight gain in adolescence, with 
healthy diet and exercise and to curb all the multifactorial etiology that leads to 
increased BMI and the further complications. 
 
  
REVIEW OF LITERATURE 
 
BODY MASS INDEX 
 
Definition 
The body mass index (BMI) or Quetelet index is a value derived from the mass 
(weight) and height of an individual. The BMI is defined as the body mass 
divided by the square of the body height and is universally expressed in units of 
kg/m2, resulting from the mass in kilograms and height in meters. 
 
Classification according to BMI[1] 
 
According to the World Health Organization 
 
Underweight BMI= <18.5 Kg/m2 
Normal BMI =18.5 to 24.9 Kg/m2 
Overweight BMI= 25 to 29.9 Kg/m2 
Obesity BMI > 30 Kg/m2 
 
  
Obesity is further categorized into, 
 
CLASS I BMI 30 to 34.9 Kg/m2 (high risk). 
CLASS II BMI 35 to 39.9 Kg/m2 (very high risk). 
CLASS III BMI > 40 Kg/m2 (morbid obese). 
 
Body mass index is now the accepted measure of underweight, overweight and 
obesity. Overweight is a bodyweight including muscle, bone, fat and body 
weight in excess of some standard or ideal body weight. Obesity is a state of the 
excess adipose tissue mass. Adipose tissue mass increases by enlargement of 
adipose cells as well as by an increase in a number of adipocytes. 
 
Prevalence 
 
According to the World Health Organization (WHO), obesity is one of the 
neglected, yet most common public health problems in both developed and 
developing countries2. According to the WHO World Health Statistics Report 
2012, globally one in six adults are obese and nearly 2.8 million individuals die 
each year due to high BMI and its complication.3 
 
  
India, the second most populous country in the world with 1.2 billion people is 
currently experiencing a rapid epidemiological transition. Undernutrition due to 
poverty which dominated in the past is being rapidly replaced by obesity 
associated with affluence. Industrialization and urbanization also contribute to 
the increased prevalence of obesity. Studies from different parts of India have 
provided evidence of the rising prevalence of increasing BMI (4,5,6,7). This 
increasing of BMI, which has been termed  an epidemic in the past has rather 
turned out to be an endemic problem in both developing and developed 
countries, creating much burden on health care. 
 
Risk Factors 
 
Individual 
○ Energy intake in excess of energy needs 
○ Calorie-dense, nutrient-poor food choices (e.g., sugar-sweetened beverages) 
○ Low physical activity 
○ Sedentariness 
○Little or excess sleep 
○ Genetics 
○ Pre- and perinatal exposures 
  
○ Certain diseases (e.g. Hypothyroidism, Cushing's disease) 
○ Psychological conditions (e.g., depression, stress) 
○ Specific drugs (e.g., steroids) 
Socioeconomic 
○ Low education 
○ Poverty 
Environmental 
○ Lack of access to physical activity resources / low walkability neighbourhoods 
○ Viruses 
○ “Obesogens” (e.g., endocrine-disrupting chemicals) 
○ Obese social ties 
 
Comorbidities and Sequelae  
o Metabolic syndrome 
o Type 2 diabetes 
o Hypertension 
o Dyslipidemia 
o Heart and vascular diseases 
o Ischemic stroke 
o Osteoarthritis 
  
o Infertility 
o Certain cancers (e.g., esophageal, colon, endometrial carcinoma) 
o Respiratory conditions/diseases (e.g., sleep apnea, asthma) 
o Liver diseases (e.g., nonalcoholic fatty liver disease, nonalcoholic 
steatohepatitis) 
o Gallstones 
o Infection 
o Deep vein thrombosis 
o Poor wound healing 
o Psychological conditions (e.g., depression, psychosocial function) 
o Physical disability 
o Years of life lost/early mortality 
o Absenteeism/loss of productivity 
o Higher medical costs. 
 
High BMI in pregnancy 
 
The rising trends of increasing BMI in women of reproductive age group is 
making pre-gravid overweight one of the most common high-risk obstetric 
conditions. When women with pre-pregnancy high BMI get pregnant, there is an 
  
imbalance in carbohydrate tolerance, hemodynamic adaptation and fetal size, 
which causes many complications like gestational diabetes mellitus, pre-
eclampsia, preterm birth, intrauterine growth retardation(IUGR), macrosomia. 
Maternal obesity increases perinatal morbidity and mortality. Attributing to the 
perinatal morbidity and the need for neonatal admissions,  the cost of hospital 
care is more for overweight mothers and their babies when compared to their 
normal weight counterparts.  
 
Preconception and high BMI 
 
Tight monitoring of weight gain, pre-pregnancy counselling and healthy dietary 
lifestyle with good physical activity can reduce this economic and social burden 
due to overweight pregnancies, even in genetically susceptible women. Due to 
central obesity, there is an increased risk for diabetes and cardiovascular disease. 
Nearly 50% of patients with the polycystic ovarian syndrome are obese. There is 
hyperinsulinemia in android obesity and ovulatory dysfunction which is 
associated with subfertility. In women with BMI>30, there is an association of 
low fecundity (Neil and Nelson Piercy 2001). High BMI appears to be a risk 
factor for spontaneous abortion in infertility treated patients. Evidence shows that 
women who conceive spontaneously are prone to miscarriages not only if they 
  
are obese (Lashen et al., 2004) but also if they are overweight (Hamilton-Fairley 
et al.). Fedorcsak et al have reported increased miscarriages after IVF in women 
with raised BMI (Fedorcsak et al., 2000). Insulin resistance due to raised BMI 
Insulin resistance due to raised BMI is an independent risk factor for spontaneous 
miscarriage, both after natural conception (Craig et al., 2002) and after ART 
treatment (Tian et al., 2007).  
 
The mechanism behind miscarriage: 
 
1. Reduced expression of Endometrial glycodelin 
2. Reduced insulin growth factor binding protein 1 
Endometrial glycodelin and insulin growth factor binding protein 1 regulate 
implantation. Giudice, 2006). 
 
Role of leptin 
1. Leptin receptors which are produced by secretory endometrium play an 
important role in regulating endometrial angiogenesis in response to the adipose 
tissue hormone leptin Gonzalez et al., 2000; Mitchell et al., 2005 
  
2. Altered plasma leptin levels and the leptin-resistant state associated with 
obesity (Enriori et al, 2006) have been shown to be associated with impaired 
trophoblastic invasion (Castellucci et al., 2000; Kawamura et al., 2003) and 
early miscarriage (Lage et al., 1999). 
3. High BMI mothers have high  leptin levels which exacerbate insulin resistance 
and thereby miscarriage Veleva et al., 2008 
Alteration in steroid hormone metabolism and adipose-tissue-dependent 
secretion of cytokines, such interleukin-6, leukaemia inhibitory factor and 
tumour necrosis factor-a (ESHRE Capri Workshop Group) plays a role in 
miscarriages. 2006; Metwally et al., 2008b; Samy et al., 2009). 
 
PRE ECLAMPSIA 
 
Pre eclampsia complicates 3-6% of pregnancies and it is associated with many 
complications like intrauterine growth restriction, placental abruption,  preterm 
delivery, labour induction and perinatal morbidity. 
Pre eclampsia is defined as hypertension occurring after 20 weeks of gestation 
combined with proteinuria. The two types are early onset and late onset 
preeclampsia. 
  
Early onset disease is due to abnormal placentation which is the most common 
cause of maternal and perinatal morbidity and mortality and late-onset pre 
eclampsia are due to maternal metabolic disease. High BMI mothers are more 
prone to have preterm pre-eclampsia than their normal counterparts(NH 
ANDERSON et all). 
SARA SOHLBERG et all showed that short stature women are more prone to 
develop severe pre-eclampsia. Studies show that not all women with abnormal 
placental perfusion develop pre-eclampsia, implying the assumption that pre 
eclampsia occurs due to factors other than placental factors like genetics and 
environmental factors. In such women, a predisposing factor such as high BMI 
can trigger low-grade inflammation ( elevated c-reactive protein, and interleukin 
-6) endothelial activation, oxidative stress, and initiation of the coagulation 
cascade and finally cause preeclampsia 
Jensen(2003), Sebire (2001), Weiss(2004) found that high BMI is a consistent 
risk factor for pre eclampsia. 
 
 
 
 
 
  
RCOG recommendations for Obesity and pre-eclampsia 
 
1.) NICE clinical guideline on hypertensive disorders during pregnancy 
suggested that those women with more than one risk factor for pre eclampsia 
may benefit from taking 75 mg aspirin starting from 12 weeks till the birth of a 
baby. 
 
2.) PRECOG 2004 (Pre-eclampsia community guideline) 
Women with pre-pregnant BMI of 35 and above with additional one risk factor 
referred to specialist care. 
 
Additional risk factors mentioned are 
1. 1.Primi 
2. 1.Previous history of pre eclampsia 
3. years and above from last child birth 
4. 40 years and above of age 
5. The family history of pre-eclampsia 
6. Booking diastolic blood pressure of 80 mm Hg and above 
7. 1+ or more proteinuria on more than one occasion 
8. 0.3 g per day or above of proteinuria 
  
9. Multiple pregnancies 
10. Underlying medical condition like APLA, pre-existing diabetes, 
hypertension, renal disease. 
 
3.) Women with pre-pregnant BMI of 30 and above with no additional risk 
factors can have routine antenatal care at a minimum of 3 weekly intervals 
between 24 to 32 weeks and at 2 weekly intervals from 32 weeks onwards. 
Exercise is found to have beneficial effects in protecting against pre-eclampsia 
by reduction of oxidative stress and by increasing placental perfusion, thereby 
preventing vascular endothelial activation. 
 
GESTATIONAL DIABETES MELLITUS 
 
Any degree of glucose intolerance that appears for the first time or is first 
recognized during pregnancy. 
 
Etiopathogenesis 
1. Adipocyte-derived pro-inflammatory peptides like tumour necrosis factor 
alpha, leptin, free fatty acids have an adverse effect on glucose metabolism. TNF 
alpha downregulates GLUT 4, which causes insulin resistance in peripheral 
  
tissue. The increased amount of Leptin inhibits insulin secretion. There is 
increased insulin resistance, a decrease in insulin receptor kinase and a decrease 
in post-receptor signalling which causes diabetes 
2. Some patients have HLA DR3, DR4 and antibodies against islet cells. 
WHO guideline: 
The diagnosis of GDM at any time during pregnancy should be based on one of 
the following values: 
– Fasting plasma glucose = 5 .1– 6 .9 mmol/L (92– 1 25 mg/dL) 
– One-hour post-75 g oral glucose load ≥ 10.0 mmol/L (180 mg/dL) 
– Two-hour post-75 g oral glucose load 8.5 – 11.0 mmol/L (153 – 199 mg/dL). 
 
RCOG Recommendations regarding Obesity and Gestational diabetes:  
 
Level 2+ evidence indicates three-fold increased the risk of developing 
gestational diabetes in obese. 
Screening for gestational diabetes is in accordance with NICE clinical guideline 
63 which suggest 2 hours oral glucose tolerance test between 24 to 28 weeks. 
All obese women with gestational diabetes offered an oral glucose tolerance test 
6 weeks after child birth. 
Regular follow up for development of type 2 diabetes for a period of 5 years. 
  
Annual screening for cardiac risk factors and healthy life style to be advised.  
 
Studies show that 
1.) Exercise decreases risk for gestational diabetes (Zhang et all 2006) 
2.) Women with high BMI are more prone to develop GDM. Odds ratio-
2.6(Weiss et all 2004)  
3.) Brisk walking for at least 25 minutes thrice a week showed decreased fasting 
and postprandial blood glucose level (Davenport et al 2008)  
 
ABRUPTIO PLACENTA 
 
Abruptio placenta is defined as the condition in which placenta is separated from 
the uterus either partially or completely. The known risk factors are increased 
maternal age, pre-eclampsia, twin pregnancy, intrauterine infections predisposing 
separation of the placenta, oligohydramnios, polyhydramnios, premature rupture 
of membranes. 
Joel G. Ray et all studied that women with metabolic syndrome are at a high risk 
of abruption placenta. the diagnostic criteria are  
1. Intraamniotic or subchorionic marginal haematoma 
2. Jelly-like a preplacental or retroplacental collection 
  
3. Placental thickness more than 5 mm 
4. Movement of the chorionic surface when fetus moves. 
5. Antepartum haemorrhage/blood stained liquor 
Underweight mothers and extremely obese mothers are at high risk of placental 
abruption. When weight gain during pregnancy is moderate it is protective 
against abruption. 
Overweight mothers are prone to intra uterine infections, pre-eclampsia, 
polyhydramnios due to gestational diabetes which makes them at risk for 
abruption. 
 
ANEMIA COMPLICATING PREGNANCY 
 
Gestational anemia is a public health problem causing burden in health care. 
National Health and examination survey (NHANES) confirmed using 
multivariate regression analysis that overweight population were twice as anemic 
as normal weight population. The hypothesis states that increased weight causes 
defective iron absorption through the inflammatory mediated mechanism. 
The pathophysiology of high BMI is the excess of adipose tissue . Obese adipose 
tissue is characterized by macrophage infiltration and local production of pro-
inflammatory cytokines such as interleukin 1, interleukin 6 and tumour necrosis 
  
factor alpha creating a low-grade inflammatory milieu. Hormonal peptides called 
as adipokines are also secreted whose expression gets markedly changed as the 
adipose tissue progresses from lean type to obese phenotype. 
1. Leptin, which produces satiety in normal individuals, is resistant in obese 
individuals who exhibit hyperleptinemia and hypothalamic leptin resistance. 
2. Resistin is the adipokine closely related to low-grade inflammation and 
cardiovascular disease. 
3. Adiponectin which is an anti-inflammatory agent and its concentration is 
found to be decreased in mothers with high BMI. 
4. Adipocyte fatty acid binding protein (A-FABP) is expressed in mature 
adipocytes which are positively associated with insulin resistance and causes 
increased lipolysis and free fatty acid efflux to the liver. 
In response to this low-grade inflammation caused by the cytokines, adipokines 
and free fatty acids, the body responds by expressing elevated hepcidin levels, 
which is produced both from liver and adipose tissue. Increased hepcidin levels 
cause decreased duodenal ferroportin absorbtion and cause decreased iron 
absorption. 
Furthermore, the pro-inflammatory cytokines interfere with erythropoietin 
production and interfere with the response of the erythroid precursors to 
erythropoietin. 
  
High plasma volume and consumption of high-calorie food with poor nutrient 
value are some of the hypothesis proposed for anemia occurring in mothers with 
high body mass index.  
Amato et all studied that there was an improvement in iron absorbtion and 
decrease in serum hepcidin after a six-month weight loss program. After 
restrictive bariatric surgery, patients were found to be with increased transferrin 
and decreased hepcidin as supported by many studies. 
 
OLIGOHYDRAMNIOS 
 
Oligohydramnios refers to an amniotic fluid volume less than that is expected for 
gestational age. It is mainly due to intrauterine growth restriction, fetal 
anomalies, Premature rupture of membranes, which are common in mothers with 
high BMI , making it a risk factor for oligohydramnios. 
The diagnostic criteria are that the deepest vertical pool is less than or equal to 1 
cm or an amniotic fluid index of less than 5 cm. 
 
 
 
 
  
PRETERM BIRTH AND PREMATURE RUPTURE OF MEMBRANES 
 
Preterm birth may be defined as the birth between the period of viability and 37 
completed weeks of gestation. Preterm birth is classified into spontaneous with 
premature rupture of membrane, spontaneous without premature rupture of 
membrane and indicated preterm birth. Rudra et al studied that indicated preterm 
birth is more in high BMI. Zhong et al reported that high BMI is associated with 
increased preterm birth with PROM, and decreased spontaneous preterm birth 
without PROM. The pathophysiology being increased levels of cytokines like 
interleukin 1 , IL 6 and tumour necrosis factor alpha cause cervical ripening, 
myometrial contractions and weakening of membranes through stimulation of 
prostaglandin production and matrix-degrading enzymes. Moreover, women with 
high BMI are more prone to intra uterine bacterial infection and 
chorioamnionitis. This inflammatory upregulation, enhanced cytokines and 
adipokines coupled with low-grade systemic infection predispose to preterm 
labour and premature rupture of membranes. Naeye et al reported that women 
with high BMI were associated with chorioamnionitis and preterm deliveries. 
 
 
 
  
INTRAPARTUM COMPLICATIONS 
 
INDUCTION OF LABOUR 
 
Women with high BMI have an increased incidence of labour induction. Labour 
is more likely to be prolonged and dysfunctional needing higher requirements of 
oxytocin and the need for operative delivery and increased morbidity. Fat 
deposition in the maternal pelvis and fetal macrosomia may contribute to labour 
dystocia and increased rates of caeserian delivery. wolfe et all demonstrated that 
the need for caeserian delivery increased with elective labour induction in 
women with high BMI with an unfavourable cervix. 
Biarco et al found an increased slow progression of labour in women with high 
BMI. Namiko et al studied that the prolongation of labour was limited to the first 
stage of labour only. Increased BMI was not associated with a difference in 
second stage duration, regardless of whether labour was induced or 
spontaneous.Moyinihan et al found that there were impairments in uterine 
contractility in women with high BMI 
Chuhan et al observed that the rates of instrumental delivery in women with high 
BMI were 13%. 
 
  
CAESERIAN SECTION 
 
The HAPO study found an association between maternal hyperglycemia and the 
rate of caeserian delivery. however sebire et al suggest that irrespective of 
gestational diabetes, high BMI is a high-risk factor for increased caeserian 
delivery. 
Neonatal macrosomia alone cannot explain the increased rates of caeserian 
delivery. the slow progress of labour in high BMI women along with labour 
dystocia leads to caeserian delivery as well. 
Dietz et al found that caeserian section for normal BMI was found to be 14.3% 
and 42.6% for women with high BMI. 
Sebire et al studied that there was an increased risk of shoulder dystocia and 
emergency caeserian section in women with high BMI. 
Cnattingius et al demonstrated increasing caeserian delivery with high BMI and 
short stature. 
Young et al studied that indications for  caesarian delivery among women with 
high BMI were mainly cephalopelvic disproportion and failure to progress 
 
 
 
  
INTRAOPERATIVE AND POST OPERATIVE COMPLICATION 
 Comorbidities associated with caeserian delivery  are anesthetic complications, 
increased operative time, Blood loss >1000ml, difficulty in delivering the baby, 
wound infection, endometritis , postoperative fever , prolonged hospital stay, 
thromboembolic manifestations. 
 
 
Anaesthetic complications: 
Ranta et al studied that in women with high BMI there were more technical 
problems in establishing epidural anaesthesia such as inadvertent dural puncture, 
multiple attempts and senior anaesthetist consultation. There was no difference in 
response to pain treatment.  
Skin incision 
Pfannenstiel incision is preferred in less centrally obese which allows early post 
operative ambulation and better respiratory function. the disadvantage is that 
more of fat tissue is cut through and the moist skin crease is exposed to infection 
leading to wound breakdown. In very obese patients, for the sake of improved 
exposure and for the sake of cutting through less fat, vertical skin incision is 
preferred. Though the wound care is better in vertical incision the disadvantage is 
that the lateral forces act upon the wound causing breakdown of the wound. 
  
NICE guidelines 13 suggest that women with high BMI should be given 
antibiotic prophylaxis in order to prevent wound infection. Also in those with 
more than 2 cm subcutaneous fat, suturing of subcutaneous tissue will reduce the 
risk of wound infection and wound separation. 
Thromboembolism: 
EDWARDS et al 461996 found the incidence of thrombo embolism to 
be 2.5% in an obese woman. 
Green Top Guideline 37 Suggest 
1. Those obese women with two or more additional risk factors for 
thrombo embolism should be started on thrombo prophylaxis in 
antenatal period itself. 
2. All woman with thromboprophylaxis in the antenatal period should be 
continued on prophylaxis for six weeks postnatally along with 
postnatal risk assessment for thrombo embolism. 
 
 
 
 
 
 
  
Weight Specific Dosage For Thrombo Prophylaxis: 
Weight (kg) DOSE 
91-130 
 
60 mg Enoxaparin or 
7500 units Dalteparin or 
7000 units Tinzaparin daily 
131-170 
 
80 mg Enoxaparin or 
10000 units Dalteparin or 
9000 units Tinzaparin daily 
>170 
 
0.6 mg/kg/day Enoxaparin or 
75 units/kg/day Dalteparin or 
75 units/kg/day Tinzaparin daily 
 
3. All obese woman advised early ambulation after delivery. 
4. All morbidly obese women should be given postnatal thromboprophylaxis 
irrespective of the mode of delivery. 
5. Also, women with BMI > 30kg/m2 with 1or more additional risk factors for 
thromboprophylaxis should be given Low Molecular Weight Heparin for 7 days 
in the postpartum period. 
  
6. BMI > 30kg/m2 with 2 or more additional risk factors for thromboprophylaxis 
should be managed with graduated compression stocking in addition to Low 
Molecular Weight Heparin. 
 
RCOG Recommendations2 for Thrombo Prophylaxis in an obese woman 
Thrombo prophylaxis with low molecular weight heparin is recommended for 
obese woman for 3 to 5 days following vaginal delivery. 
Thrombo prophylaxis recommended before and also after cesarean section for 3 
to 5 days. 
 
LACTATION: 
 
Li et al demonstrated lactational dysfunction in women with high BMI. The 
excess weight gain during pregnancy gained by women with high BMI as studied 
by catalano et al is difficult to shed in post partum period, which causes parous 
obesity. 
 
 
 
 
  
POSTPARTUM  DEPRESSION 
 
Varner et al found increased incidences of post partum depression in women with 
high BMI. the severity increased in relation to the degree of obesity. 
Class I(22.6%) ,ClassII(32.4%),Class III(40%) 
 
PERINATAL COMPLICATIONS 
 
STILL BIRTH 
 
Huang et al found an increased incidence of unexplained fetal death in women 
with high BMI. Cedergren et al found that odds ratio for still birth with BMI 
more than 35 is 2.79. The reasons for increased still birth is suggested due to 
uteroplacental insufficiency due to atherosclerosis, chronic hypertension, birth 
defects and macrosomia due to diabetes, decreased ability to perceive fetal 
movements and increased incidence of sleep apnea which results in oxygen 
desaturation and hypoxia. 
 
 
  
IUGR 
 
Studies show that Babies born to mothers with high BMI have higher incidences 
of IUGR due to chronic hypertension, uteroplacental  insufficiency, pre 
eclampsia, anaemia. 
 
MACROSOMIA 
 
Prepregnancy weight and maternal weight gain during pregnancy play an 
important role in determining infant birth weight. The prevalence of macrosomic 
infants is increased in women with high BMI. 
 
 
 
 
 
 
 
 
 
 
 
  
OBESITY-RELATED PREGNANCY COMPLICATIONS 
Author, 
Year 
Medical 
Complication 
Antepartum 
Complication 
Intrapartum 
Complication 
Postpartum 
Complication 
Perinatal 
Complication 
Edward
s et 
al 
197824 
 
 Hypertensive 
disorders of 
pregnancy, Mild 
Preeclampsia, 
Gestational 
diabetes, 
inadequate 
pregnancy weight 
gain 
 Wound 
episiotomy 
infection 
 
 
Birth weight 
>4kg 
 
Gross et 
al 
198042 
 
Hypertension 
Diabetes 
mellitus 
 
Gestational 
diabetes, 
Multiple gestation, 
inadequate weight 
gain 
Labor 
induction 
Fourth 
degree 
laceration 
 Birth weight 
>4kg 
LGA 
 
Calandr
a et 
al.19811
3 
  Labor 
Induction 
Fever Birth Weight 
>4kg 
Garbaci
ak et al 
198535 
 
Hypertension 
Diabetes 
mellitus 
Thyroid 
disease 
Pre-eclampsia, 
Urinary 
tract infection 
 
Primary 
cesarean 
Meconium 
Late 
decelerations 
  
Abrams 
et 
al, 
19883 
 
Hypertension 
diabetes 
mellitus 
Pregnancy 
induced 
hypertension, 
Gestational 
diabetes 
Primary 
cesarean 
 
  
Naeye, 
199070 
 
Hypertension 
Diabetes 
mellitus 
Preterm birth < 
30wks, 
Twins 
  Congenital 
anomaly 
Perinatal 
mortality 
Perlow 
et al, 
199279 
 
Hypertension 
Diabetes 
mellitus 
 
Gestational 
diabetes 
Cesarean, 
primary 
cesarean 
 
 Birth 
weight<2.5kg   
Birth weight 
>4kg 
SGA 
  
NICU 
admission 
Johnson 
et 
al,19925
2 
 Postdates Labor 
induction 
cesarean, 
Meconium 
 Birth Weight 
>4kg 
 
Cnatting
ius et al 
199819 
Diabetes 
mellitus 
Gestational 
diabetes, 
Pre-eclampsia, 
Preterm 
birth <32wks 
  Late fetal death 
Early neonatal 
death. 
Bianco 
et 
al,19981
1 
 
Hypertension 
Diabetes 
Mellitus 
Pre-eclampsia, 
Gestational 
diabetes, 
Abruption 
Meconium, 
Labor arrest, 
Cesarean 
Endometritis LGA 
Baeten 
et al 
20019 
 
 Gestational 
diabetes, 
Pre-eclampsia, 
Preterm birth 
<32wks 
Cesarean  Birth weight 
>4kg 
Infant death. 
 
Sebire 
et al, 
200187 
 
 Gestational 
diabetes, 
Pre-eclampsia, 
Urinary 
tract infection 
Labor 
induction, 
Emergency 
Cesarean 
Hemorrhage 
Genital tract 
infection 
Wound 
infection 
LGA Fetal 
Death 
Delayed 
lactation 
 
Lu et al, 
200164 
Ehrenbe
rg et al, 
200226 
 
Diabetes 
Mellitus 
 
Gestational 
diabetes, 
Pre-eclampsia, 
Post term 
gestation 
Cesarean 
 
 LGA 
Birth weight 
>4kg 
Birth 
weight>4.5kg 
Jensen 
et al, 
200351 
 
 Postterm 
gestation, 
Pre-eclampsia 
Labour 
Induction, 
Cesarean 
 LGA, Birth 
Weight 
>4kg. 
Clinical Obstetrics and Gynecology (Brown Journal, Vol. 47; No-4:900-901, 2004 
  
AIM  AND  OBJECTIVE 
          
1. To compare the antepartum, intrapartum, postpartum and neonatal outcome in 
pregnant mothers with high body mass index in the first trimester with those of 
normal body mass index.   
2. To  find the incidence of complications in mothers with high body mass index. 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
This prospective study was conducted in the Department of Obstetrics and 
Gynecology, Madras Medical College, Chennai. Written informed consent was 
obtained from all antenatal women who participated in the study. 
Subject Selection:  
Subjects are selected from the Antenatal OPD of Madras Medical College. 
Inclusion Criteria: 
1) Primi gravida  pregnant mothers  below 12 weeks of gestation                                                                                                                                   
Exclusion Criteria 
1)Patients not  willing for the study  
2)Multiple pregnancies 
3) Women with medical disorders, Diabetes, hypertension.  
METHODOLOGY: 
Pregnant women visiting the antenatal op, in the early trimester after getting 
written consent were registered. Detailed history taking and examination were 
  
carried out with the measurement of body mass index as weight in kg/height in 
meter square.                                                                              
The subjects were classified into 2 groups 
GROUP 1- NORMAL –BMI (20-24.9) 
GROUP 2 -  OVERWEIGHT and OBESE (BMI 25 and above) 
Follow up procedure: 
The women were followed up for the antepartum, intrapartum, post partum 
variables and neonatal outcome. 
The data were analysed for the 2 groups of patients in the study. 
 
Assessment of parameters: 
1) ANTENATAL VARIABLES: 
Abortion 
Preeclampsia 
Gestational diabetes mellitus 
Oligohydramnios 
  
Abruptio placenta 
Anaemia 
PROM 
2) INTRAPARTUM VARIABLES 
Vaginal delivery 
Caeserian section 
Instrumental delivery 
3) POSTPARTUM VARIABLES: 
PPH 
Duration of hospital stay 
Wound infection/gaping 
Pyrexia 
Lactational dysfunction 
4) NEONATAL VARIABLES: 
IUGR 
Preterm 
  
Macrosomia (>4 kg) 
Post-term 
Still birth 
NICU Admission 
Need for intubation. 
 
Statistical analysis plan 
Statistical comparison between data of cases (BMI>25) and controls (BMI<25) 
was performed with Chi-square test and a P value of less than 0.05  denotes 
statistical significance. 
 
 
 
 
  
RESULTS AND ANALYSIS 
 
Two hundred pregnant women with high BMI >25 kg/m2 and two hundred 
pregnant women with normal BMI were selected and were followed 
prospectively. 
 
1. MATERNAL AGE DISTRIBUTION: 
 
 
About 50% of women with normal BMI are in the age group between 20 to 24 
years and in the high BMI group about 43.5% fall in the age group between 20 to 
24 years. 
 
AGE 
(YEARS) 
 
Normal BMI High BMI 
No Percentage No Percentage 
<20 13 6.5 7 3.5 
20-24 101 50.5 87 43.5 
25-29 70 35 80 40 
> 30 16 8 26 13 
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2. MISCARRIAGE RATE 
 
 
 
 
 
Chi square = 1.641, p = 0.200 
 
 
The rate of miscarriage in our study was 1.5% among women with normal BMI 
and 3.5% among women with high BMI. 
In our study, as the p value is greater than 0.05, BMI and abortion was found to 
be independent of each other. 
 
 
 
 
 
Normal BMI (n = 200) High BMI (n = 200) 
No Percentage No Percentage 
Abortion 3 1.5 7 3.5 
Live 197 98.5 193 96.5 
  
 
3. PRE ECLAMPSIA: 
 
 
 
 
 
 
 
 
 
Chi square = 27.100, p = 0.001(p<0.05) 
 
In our study, women with high BMI had 28% incidence of pre eclampsia and 
those with normal BMI had 8% incidence. 
As the p value is less than 0.05, BMI and pre eclampsia was found to be 
dependent of each other. 
 
 
 
 
 
Pre 
eclampsia 
Normal BMI (n= 200) High BMI (n=200) 
No Percentage No Percentage 
Mild 12 6 21 10.5 
Severe 4 2 35 17.5 
Total 16 8 56 28 
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4. GESTATIONAL DIABETES MELLITUS 
 
 
 
 
 
 
 
 
 
 
Chi square = 27.706,  p = 0.001(p<0.05) 
 
 
In our study, women with high BMI had 27.5% incidence of gestational diabetes 
mellitus and those with normal BMI had 7.5% incidence. 
As the p-value is less than 0.05, BMI and gestational diabetes mellitus were 
found to be dependent on each other. 
It was found that BMI influences gestational diabetes mellitus. 
 
 
 
GDM 
Normal BMI (n= 200) High BMI (n=200) 
No Percentage No Percentage 
Meal plan 12 6 22 11 
Insulin 3 1.5 33 16.5 
Total 15 7.5 55 27.5 
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5. OLIGOHYDRAMNIOS 
 
 
 
Chi square = 0.190, p = 0.663(p>0.05) 
 
In our study, women with high BMI had 14.5% incidence of oligohydramnios 
and those with normal BMI had 13% incidence. 
As the p-value is more than 0.05, BMI and oligohydramnios were found to be 
independent of each other. 
 
 
 
 
Oligohydramnios Normal BMI (n= 200) High BMI (n=200) 
 
No of cases 26 29 
Percentage 13 14.5 
  
 
 
6. ABRUPTIO PLACENTA 
 
 
 
 
 
 
 
 
Chi square = 0.233, p = 0.630(p>0.05) 
 
 
In our study, women with high BMI had 5% incidence of abruption and those 
with normal BMI had 4% incidence. 
As the p-value is greater than 0.05, BMI and abruption were found to be 
independent of each other. 
 
 
 
 
 
Abruption Normal BMI (n= 200) High BMI (n=200) 
 
No of cases 8 10 
Percentage 4 5 
  
 
 
7. ANEMIA 
 
 
 
 
 
 
 
 
 
Chi square = 1.157, p = 0.283 (p>0.05) 
 
 
In our study, women with high BMI had 7% incidence of anaemia and those with 
normal BMI had 10% incidence. 
As the p-value is greater than 0.05, BMI and gestational diabetes mellitus were 
found to be independent of each other. 
 
 
 
Anemia Normal BMI (n= 200) High BMI (n=200) 
 
No of cases 20 14 
Percentage 10 7 
  
 
 
8. PROM 
 
 
 
Chi square = 0.086, p = 0.770(p>0.05) 
 
 
 
In our study, women with high BMI had 14% incidence of PROM and those with 
normal BMI had 13% incidence. 
As the p-value is less than 0.05, BMI and gestational diabetes mellitus were 
found to be independent of each other. 
 
 
 
PROM Normal BMI (n= 200) High BMI (n=200) 
 
No of cases 26 28 
Percentage 13 14 
  
 
 
9. ANTEPARTUM PARAMETERS 
 
 
 
 
 
 
 
 
 
 
Complications 
Normal BMI 
(n = 200) 
High BMI 
(n = 200) 
P 
value 
Chi - 
square 
No Percen
tage 
(%) 
No Perce
ntage 
(%) 
  
Pre-eclampsia 16 8 56 28 <0.05 27.1 
GDM 15 7.5 55 27.5 <0.05 27.7 
Oligo 26 13 29 14.5 0.66 0.19 
Abruption 8 4 10 5 0.63 0.23 
Anemia 20 10 14 7 0.28 1.15 
PROM 26 13 28 14 0.77 0.09 
  
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
PIH GDM OLIGO ABRUP ANEMIA PROM
N
U
M
B
ER
 O
F 
C
A
SE
S
PREGNANCY RELATED COMPLICATION 
Normal BMI
High BMI
  
 
 
10. INDUCTION OF LABOUR 
 
 
 
 
 
 
 
 
Among the patients with high BMI, the induction rate was 36.78% and for 
normal BMI, the induction rate was 26.39%. 
 
 
 
 
 
 
 
 
 
 
 
Normal BMI High BMI 
No Percentage No Percentage 
Induced 52 26.39 71 36.78 
Non 
induced 
145 73.60 122 63.21 
  
 
 
11. REASON FOR INDUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In our study, the most common cause for induction of labour among mothers 
with high BMI was pre-eclampsia with a percentage of 30.81% and in mothers, 
with normal BMI it was oligohydramnios with a percentage of 24.96 %. 
GDM accounted for 28% of induction in mothers with high BMI and for  11.5%  
of induction in mothers with normal BMI 
 
 
Normal BMI High BMI 
No Percentage(%) No Percentage(%) 
GDM 6 11.50 20 28 
Pre- 
eclampsia 
11 21.12 22 30.81 
Oligo 13 24.96 6 8.42 
IUGR 11 21.12 13 18.23 
Post dated 2 3.84 4 5.6 
PROM 9 17.28 6 8.4 
Total 52 99.92 71 99.89 
  
Pre-eclampsia accounted for 30.81% of induction in mothers with high BMI and 
for21.12  %  of induction in mothers with normal BMI 
 Oligohydramnios accounted for 8.4 % of induction in mothers with high BMI 
and for 24.96 % of induction in mothers with normal BMI 
IUGR accounted for 18.23% of induction in mothers with high BMI and for 
21.12 % of induction in mothers with normal BMI 
Post dated accounted for 5.6 % of induction in mothers with high BMI and for  
3.84%  of induction in mothers with normal BMI. 
PROM accounted for 8.4 % of induction in mothers with high BMI and for  
17.28 %  of induction in mothers with normal BMI 
 
 
 
 
 
 
 
 
 
 
  
12. MODE OF DELIVERY 
 
 
 
 
 
The incidence of vaginal delivery, instrumental delivery and LSCS was found to 
be 57.5%, 9.5% and 31.5% respectively in women with normal BMI and 
32.5%,9.5% and 54.5% in women with high BMI respectively. 
The table shows that vaginal delivery and LSCS are dependent on BMI as their 
corresponding P value is found to be less than 0.05. 
Instrumental delivery was found to be equal in both the groups and the p-value 
was found to be 1(not statistically significant). 
 
Complications 
Normal BMI High BMI P 
value 
Chi 
Square 
No % No %   
Vaginal 115 57.5 65 32.5 0.001 25.25 
Instrumental 19 9.5 19 9.5 1 0 
LSCS 63 31.5 109 54.5 0.001 21.58 
  
 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
VAGINAL INSTRUMENTAL LSCS
N
U
M
B
ER
 O
F 
C
A
SE
S
MODE OF DELIVERY
Normal BMI
High BMI
  
13. INDICATION FOR CAESERIAN SECTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In our study, failed induction was the most common cause of indication of the 
primary caesarian section in normal BMI with 23.7% .cephalopelvic 
disproportion was  the most common cause of primary caesarian section in high 
BMI group with 30% 
Causes  Normal BMI  High BMI 
No Percentage 
(%) 
No Percentage(
%) 
Fetal distress 12 18.96 18 16.56 
Failed 
induction 
15 23.7 27 24.84 
Cephalopelvic 
disproportion 
14 22.12 30 27.62 
Failure to 
progress 
6 9.48 11 10.12 
Imminent 
eclampsia 
- 0 4 3.68 
Malpresentation 11 17.38 14 12.7 
Failed 
instrumental 
delivery 
2 3.16 2 1.74 
Deep transverse 
arrest 
1 1.58 2 1.84 
Placenta previa 2 3.16 1 0.92 
Total 63 99.59 109 99.92 
  
14. POSTPARTUM COMPLICATION 
 
 
 
 
The incidence of PPH in women with high BMI was found to be 3.5% and the 
incidence of women with low BMI was 5.5%, the p-value was more than 
0.05(not statistically significant). 
 
Complications 
Normal BMI High BMI P 
value 
X2 
No Percentage No Percentage   
PPH 11 5.5% 7 3.5% 0.335 0.931 
Pyrexia 1 0.5% 2 1% 0.562 0.336 
Wound 
Gaping 
3 1.5% 9 4.5% 0.079 3.093 
Prolonged 
stay 
1 0.5% 6 3% 0.057 3.635 
Lactation 
Dysfunction 
0 0 5 2.5% 0.024 5.063 
  
The incidence of pyrexia in women with high BMI was found to be 1% and the 
incidence of women with low BMI was 0.5%, the p-value was more than 
0.05(not statistically significant). 
The incidence of wound gaping in women with high BMI was found to be 4.5% 
and the incidence of women with low BMI was 1.5%, the p-value was less than 
0.05(statistically significant). 
the incidence of a prolonged stay in women with high BMI was found to be 3% 
and the incidence of women with low BMI was 0.5%, the p-value was more than 
0.05( not statistically significant) 
The incidence of lactational dysfunction in women with high BMI was found to 
be 2.5% and the incidence of women with low BMI was 0, the p-value was less 
than 0.05( statistically significant) 
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15. BIRTH WEIGHT OF THE NEONATE 
 
 
 
 
 
 
 
 
 
 
 
 
 
In our study, the majority of the babies had a birth weight falling between 2.5 to 
2.9 kg with 44% and 33.5% in normal BMI and high BMI group respectively. 
Birthweight more than 4 kg was found to be 17% in the high BMI group and 2% 
in the normal BMI group, which was statistically significant. 
Extremely low birth weight babies falling between birthweight 1.5 to 1.9 kg was 
found to be more in high BMI group with 9.5%compared to 4% of normal BMI 
group, accounting for induction of labour due to pre-eclampsia in mothers with 
high BMI 
 
Birth 
weight 
Normal BMI High BMI 
No Percentage No Percentage 
1.5 – 1.99 8 4 19 9.5 
2 – 2.49 52 26 20 10 
2.5 – 2.99 88 44 67 33.5 
3 – 3.49 35 17.5 49 24.5 
3.5 – 3.99 12 6 21 10.5 
>4 2 1 17 8.5 
  
15. NEONATAL COMPLICATION 
 
 
 
 
The 
inci
den
ce 
of 
IU
GR   in babies born to mother with normal BMI  is 9.5%and those born to high 
BMI is   10%. the p-value is more than 0.05. ( not statistically significant) 
The incidence of preterm in babies born to mother with normal BMI  is 12.5% 
and those born to high BMI is  6%. the p-value is less than 0.05. (statistically 
significant) 
The incidence of macrosomia in babies born to mother with normal BMI  is 1% 
and those born to high BMI is  8.5%. the p-value is less than 0.05.(statistically 
significant) 
 
Complications 
Normal BMI High BMI P 
value 
X2 
No Percentage No Percentage   
IUGR 19 9.5% 20 10% 0.124 2.37 
Pre term 25 12.5% 12 6% 0.025 5.033 
Macrosomia 2 1% 17 8.5% 0.001 12.433 
Still Birth 1 0.5% 5 2.5% 0.100 2.707 
Post term 2 1% 4 2% 0.411 0.677 
NICU stay 33 16.5% 49 24.5% 0.048 3.927 
  
The incidence of still birth in babies born to mother with normal BMI  is 0.5% 
and those born to high BMI is 2.5%  .p value is more than 0.05.(not statistically 
significant) 
The incidence of post dates in babies born to mother with normal BMI  is 1% and 
those born to high BMI is 2%. the p-value is more than 0.05.(not statistically 
significant) 
The incidence of NICU stay in babies born to mother with normal BMI  is 16.5% 
and those born to high BMI is  24.5%. p-value is less than 0.05.(statistically 
significant) 
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DISCUSSION 
 
AGE DISTRIBUTION: 
 
The age distribution in our study showed that about 50% of women with normal 
BMI are in the age group between 20 to 24 years and in the high BMI group 
about 43.5% fall in the age group between 20 to 24 years. as age advances, the 
percentage of women in high BMI group are more than in normal BMI. 
  
ABORTION:   
 Cavelcant et al in their meta-analysis studied that there was an association 
between obesity and recurrent pregnancy loss(or, 1.75; 95% ci, 1.24-2.47; 
p = 0.001). Threefold increased the risk of miscarriage was demonstrated in the 
study by Yu C et al. 
In our study, abortion was found to be more in high BMI group when compared 
to normal BMI group in accordance with the above studies but p-value was 
found to be less than 0.05, may be owing to the small size of the sample. 
 
  
PRE ECLAMPSIA: 
Our study showed an increased incidence of pre-eclampsia in patients with high 
BMI (28% as compared to 8% of the normal BMI.p value was found to be less 
than 0.05 and was statistically significant in accordance with other studies. 
 Heather E. Robinson et al 2005  showed the incidence of  18.9 -22.6% 
Glady et al 2005 showed the incidence of 16%. O’Brien and associates (2003) 
reported that preeclampsia risk doubles with each 5 -7 kg/m2  increase in 
prepregnancy BMI. 
Kumari et al (2001) reported that preeclampsia in women with high BMI was 14-
25%.  
Catalano et al 2007 and beaten et al 2001 found two-fold increased the risk of 
pre-eclampsia in overweight and three-fold increased the risk in obese. 
 
GESTATIONAL DIABETES MELLITUS: 
Our study showed a higher incidence of Gestational diabetes mellitus among 
women with high BMI with a value of 27.5 % compared to a value of  7.5% in 
women with normal BMI.GDM on insulin was found to be 16.5% in the high 
BMI group and 1.5% in women with normal BMI. The p-value was found to be 
less than 0.05 and it was statistically significant.  
  
Weiss et al in the faster trial showed a marked increase in diabetes in women of 
high BMI with the incidence of 12.3%. 
Gabee et al 1986 studied that in normal BMI only 1-3% are diagnosed with 
GDM, but in women with high BMI is 17%. 
Sebire et al 2001 found that the odds ratio was 3.6 in women with high BMI. 
Mandal et al  studied that odds ratio was found to be 19.43. 
 
OLIGOHYDRAMNIOS: 
Oligohydramnios was found to occur in 13% of women with normal BMI and 
14.5% of women with high BMI. It was found that oligohydramnios occurs 
independently of BMI and was not statistically significant.  
 
ABRUPTION: 
In our study, placental abruption was found to occur in 4% of normal BMI group 
and 5% of mothers in higher BMI group. the result was not statistically 
significant, not conforming with the following studies, may be due to a small 
sample size. 
Bainco et al showed an increased incidence of abruption, but results of Wolf HM 
et al 1994 including ours did not show an association. 
  
Joel G.Ray et all studied that women with metabolic syndrome are at a high risk 
of abruption placenta. 
ANAEMIA: 
The incidence of anaemia in women with normal BMI was 10% and in high BMI 
was 7%. P value was not statistically significant. 
 
PREMATURE RUPTURE OF MEMBRANES: 
Naeye reported that overweight and obesity were associated with increased rates 
of chorioamnionitis in preterm deliveries and that this increase was larger at 24 
to 30 weeks than at 31 to 37 weeks. 
Cnattingus et al maternal overweight and obesity during pregnancy was 
associated with increased risks of preterm delivery, especially extremely preterm 
delivery. 
Baeten et al 2001   too showed an increased risk of preterm delivery in women 
with high BMI. However, Sebire et al 2001 showed no difference. 
In our study preterm delivery was found to be more in women with normal BMI 
with a value of 12.5% compared to the value of 6% in women with high BMI. As 
the p-value was less than 0.5, it was found that preterm delivery and BMI were 
dependent on each other. 
 
  
INDUCTION OF LABOUR 
Cedergren et al, 200465 in his study had an incidence ranging from 13.1% -
18.3% according to the severity of obesity.  The risk of induction among obese 
women was increased by almost 2.5 fold according to Ekblad U et al 1992. 
In our study, the most common reason for induction in women with high BMI 
was pre-eclampsia(30.81%).oligohydramnios(24.96%) was the main factor 
leading to induction in the normal BMI group. labour induction was done in 
36.7% of women with high BMI and in 26.3% of women with normal BMI. 
Induction was done more in the high BMI group. 
. This also correlates well with the study of Sebire et al (2001) who reported 
increased rates of labour induction in obese women. But in another study, Bianco 
et al (1998) reported the rate of oxytocin augmentation was similar in both the 
groups. 
MODE OF DELIVERY: 
L-Weiss et al 2001  and Marie  Cedergren 2004   have demonstrated an 
increased risk for cesarean delivery in patients with high BMI. 
Joshua. L. Weiss et al, 2001, Marie. I Cedergren 2004 demonstrated an increased 
number of instrumental delivery in women with high BMI However Sebire NJ, et 
al 2001 studied that no increased risk of instrumental delivery was seen among 
women with high BMI. 
  
 
Our study is in accordance with the study of Hugh.Ehrenberg (2004) who 
reported a higher chance of cesarean delivery in obese women (13.8% versus 
7.7%, P< 0.0001). Lynch and associate (2008), Poobalan and colleagues (2009) 
also found that obese women have an increased rate of cesarean delivery. Sebire 
(2001) and Baeten et al (2001) and Bianco et al (1n 1998) reported an increased 
cesarean rate in obese women of more than 30%. 
WEISS JL et al21 2004 found the rate of cesarean section to be 34% in obese and 
30% in overweight. 
DIETZ et al15 2005 found a rate of camera section to be 14.3% for lean 
individuals (BMI<20)and 42.6% for obese (BMI>35).Also, the relative risk of 
cesarean without any other complications is 1.4 for overweight and 1.5 for obese. 
In our study, caesarian delivery was found in 54.5% of the high BMI mothers 
compared to 31.5% in normal BMI mothers.p-value was less than 0.05, and was 
statistically significant. Vaginal delivery was found to occur more in normal BMI 
mothers with a percentage of 57.5 compared to 32.5% in the high BMI group. 
vaginal delivery and BMI  are dependent on each other as suggested by p 
value<0.05. 
Instrumental delivery was equal in both groups with 19%  which is contradictory 
to the studies that say that instrumental delivery is higher in high BMI group. the 
  
increased rate of caesarian deliveries may explain the decrease in instrumental 
deliveries. 
The most common indication for lscs in high BMI mothers was cephalo-pelvic 
disproportion(27.62%). Failed induction (23.7%) is the most common indication 
in normal BMI group. 
Other indications are fetal distress(18.96% and 16.56% ),failure to 
progress(9.48% and 10.12%),malpresentations (17.38% and 12.7%),deep 
transverse arrest(1.58 %and 1.84%),placenta previa(3.16% and 0.92%),failed 
instrumental delivery(3.16%  and 1.74%) in normal BMI group and high BMI 
group respectively. 
Imminent eclampsia(3.68%) was also an indication in high BMI group  
 
POSTNATAL COMPLICATIONS 
Sebire et al (2001) reported a higher incidence of PPH and prolonged labour  in 
high BMI Mothers. Usha Kiran et al in studies outcome of pregnancy in a 
woman with high BMI found that adverse maternal and fetal outcome proceed 
with labour and delivery. The odds ratio for Postpartum haemorrhage was found 
to be 1.5. 
  
In our study, PPH  was found in 3.5% of mothers with high BMI and in 5.5% of 
mothers with normal BMI. The result was not statistically significant as the p-
value was less than 0.05.   
In studies on short and, long-term implications of maternal obesity on mother 
and offspring found an increased  risk of  postoperative complications like 
wound infection, excessive blood loss and postpartum endometritis. 
Myles et al 2002, Wolf HM et al 1998, cataleno et al women with high BMI to 
be at a greater risk of post-operative wound infection and wound dehiscence. 
Obese women had 2.47 fold and 3.12 fold increased the risk for wound infection 
and dehiscence respectively.  
In our study, pyrexia was found in 1% of mothers with high BMI with a p-value 
of 0.5. Wound gaping  was found with an incidence of 4.5% in high BMI 
mothers with a p-value of 0.079 (statistically significant). There was prolonged 
stay in 3% of mothers with high BMI and lactational dysfunction was found in 
2.5% (p <0.05). 
Also, thromboprophylaxis is routinely practised in our Hospital for women with 
prepregnant body mass index more than or equal to 25 regardless of the mode of 
delivery and also early ambulation is advised to our patients and so there are nil 
cases of deep venous thrombosis. 
 
  
 
 
 
NEONATAL COMPLICATION 
 
Sibire et al 2001 studied that women with high BMI had increased risk of 
delivering high birth weight babies. Similarly, Hugh M.Ehrenberg et al (2004) 
showed that obese women were at a higher risk of delivering large for gestational 
age babies (LGA) compared to women with normal weight(16.8% vs. 10.5%; 
P<0.0001). 
Sebire et al (2001), Baeten et al (2001) and Ray et al (2001) also reported that 
high maternal BMI is associated with an 18% incidence of LGA neonates, which 
is a two-fold increase over rates found in non-obese controls. 
In our study, the birth weight of babies born to women with high BMI as well as 
normal BMI fell between 2.5kg to 3kg with 44% of babies in normal BMI group 
and 33.5% of babies in high BMI group mothers. as the birth weight increases 
from above 3 kg, the percentage of babies in high BMI group is increasing.more 
than 4 kg baby was found in 8.5% of babies born to high BMI mothers compared 
to 1% in normal BMI group. 
  
According to Hood et al 1993, obese women had prolonged hospital stay, which 
may be due to associated medical complications, wound infection and NICU 
admission. 
In our study, IUGR was found in 10% of babies of women with high BMI with a 
p-value of 0.124, macrosomia was found in 8.5% of babies of a mother with high 
BMI with a significant p-value of less than 0.05. Still birth occurred in 2.5% of 
deliveries of high BMI mothers compares to 0.5% in mothers of normal BMI 
group supporting the study of Cedergren et al with an odds ratio for stillbirth in 
BMI > 35kg/m2 to be 2.79. Maternal obesity more often leads to intrauterine 
fetal death. A recent Swedish study found a three-fold higher risk in women with 
morbid obesity.  
Our study has similar results with that of Stephansson et al. The risk of 
intrauterine fetal death obviously seems to be influenced by the degree of 
obesity. 
NICU admission was found in 24.5% of babies born to mothers with high BMI 
compared to 16.5% of babies born to mothers with normal BMI with a 
significant p-value of less than 0.05. 
 
 
  
SUMMARY 
  
Our study was conducted involving 200 primi gravida with normal body mass 
index and 200 primi gravida with high body mass index, who were booked at 
their first trimester, excluding women with medical disorders and multiple 
pregnancies. 
They were followed up prospectively for the antepartum, intrapartum, 
postpartum and post-natal variables. 
 
The study demonstrated the following observation 
 
1. Majority of the women with normal BMI and high BMI were in the age group 
between 20 to 24 years. this may reflect on the current change in food pattern and 
sedentary lifestyle with lack of exercise. This focuses on the need to give advice 
to adolescent girls to have healthy dietary pattern and lifestyle in order to curb 
this epidemic of increased body weight causing health burden. 
 
2. As age advances, the percentage of women with high BMI were more than that 
of women with low BMI. 
  
 
3. Miscarriage rate was higher in high BMI group with an incidence of 3.5% in 
accordance with previous studies, yet p-value was insignificant owing to a lesser 
number of the study population. 
 
4. Pre-eclampsia was seen with a higher incidence in the high BMI group with an 
incidence of  28%  of which 17.5% was the incidence of severe pre 
eclampsia.women in normal BMI group exhibited lesser incidence(8%) with 
nearly 6% having mild pre-eclampsia. Pre-eclampsia was found to be associated 
with high BMI  as per previous studies with a statistically significant p-value. 
 
5. The incidence of Gestational  Diabetes mellitus was found as 55% in the high 
BMI group with nearly 33% on insulin.GDM was dependent on BMI as the 
previous studies declare with a significant p-value. 
 
6. Oligohydramnios was found to have no significance with body mass index in 
our study. 
 
7. Abruptio placenta incidence was 5% in high BMI group which was 
comparable to 4% in normal BMI group  
  
 
8. Premature rupture of membranes was having almost equal incidence in both 
the groups in our study.(normal BMI -13%,high BMI-14%). 
 
9. Anaemia was found to occur more in normal BMI group with an incidence of  
10% than in high BMI group(7%). This may be due to the socio-economic class 
of the study population involved. 
 
10. Induction rate was higher in the high BMI group in accordance with the 
previous studies with nearly 36.78% of women getting induced. Pre-eclampsia 
(30.81%) was the most common cause of induction in the high BMI group while 
oligohydramnios (24.96%)was the most common cause in the normal BMI 
group. 
 
11. Vaginal delivery was found to occur with a higher incidence in normal BMI 
group(57.5%) while the caesarian section was found with a higher incidence in 
high BMI mothers(54.5%), both were statistically significant. 
 
12. Instrumental deliveries were found to be equal in both the groups which are 
contradictory to previous studies that say that instrumental deliveries were higher 
  
in high BMI group.this may be owing to the higher caesarian rates in high BMI 
group. 
 
13. The most common indication for LSCS in high BMI group was 
cephalopelvic disproportion(27.62%), while in normal BMI group it was failed 
induction (23.7%), followed by cephalopelvic disproportion (22.12%) and fetal 
distress(18.96%). 
 
14. Malpresentation was found in nearly 12.7% of women with high BMI. 
 
15. Postpartum  Haemorrhage incidence was3.5% in high BMI group 
 
16. Wound gaping and lactational dysfunction were found to be statistically 
significant in the high BMI group. 
 
17. Prolonged hospital stay was seen in 3% of women in high BMI group due to 
medical and neonatal complications. 
 
18. Majority of babies born to mothers in both the group fell between 2.5 to 
2.9kg, 44% in normal BMI, 33.5%  in high BMI. 
  
 
19. Birthweight more than 4 kg was found in 17% of babies born to mothers with 
high BMI in accordance with the previous studies and was found to be 
statistically significant. 
 
20. Still birth rate was found in 2.5% of babies born to mothers with high BMI. 
 
21. NICU admission was statistically significant in the high BMI group with an 
incidence of 24.5%. 
 
22.  The Preeclampsia, GMD, Vaginal Delivery, LSCS, Lactation Dysfunction, 
Preterm, Macrosomia and NICU Admission are found to be dependent with BMI 
as their corresponding p-value of chi-square test is less than 0.05. 
 
 
 
 
  
CONCLUSION 
 
The inference from our study is that the obstetric and neonatal complications are 
more in women with high body mass index and obesity, which pose a challenge 
to the obstetrician.in addition, the weight gained in pregnancy is continued as 
health issues in the late 40s and 50s. It is also proved that the weight gain in 
prepregnancy is continued more during pregnancy where these women are 
provided with plenty of rest and food. 
So the obstetrician is needed to be well versed with dietary advice and life style 
pattern advice to the women of the reproductive age group in order to prevent the 
complications of high Body mass index in pregnancy. Hence, there is a lot of 
support needed from medical personnel to help these women to get counselled 
about the pre-pregnancy loss of weight, healthy food and exercise, and healthy 
life style pattern during pregnancy also in order to have a healthy mother and 
baby. 
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PROFORMA 
 
EFFECT OF HIGH BMI IN PREGNANCY  
 
Name of patient :                                              Age : 
Hospital no :                                                     Patient No. : 
Name of husband : 
Permanent address : 
Temporary address : 
Contact no : 
Date of visit to hospital 
Socioeconomic status : Class I / II / III / IV / V 
Educational status :                                             Employment status : 
Obstetric code : Primi 
Primi  -conceived spontaneously/after infertility treatment: 
Menstrual cycles : Regular/Irregular 
Lmp :                                                                    Edd : 
Marital history : 
Married since 
Consanguinuity : Non Consanguineous/I degree/2nd/3rd/4th 
Diet history : Vegetarian/Non–VegeterianLifestyle 
Exercise history : Regular Walking/ Labourer /Other forms 
Known case of Diabetes Type 2 : Yes / No. 
Known case of Hypertension : Yes / No 
Any other significant past history : Yes / No 
Family history of diabetes : Mother/Father/Both/none 
Family history of hypertension : Mother/Father/Both/none 
Family history of obesity: Mother/Father/Both/None 
 
Examination: 
Height(meters) 
Weight(kg) 
Body Mass Index(kg/m2) 
  
Blood Pressure 
CVS 
RS 
Anemia 
Pedal edema 
Per abdomen 
Per vaginal 
 
Investigations 
Blood grouping and typing 
HIV 
Hb 
Urine Albumin &Sugar 
Blood Urea ,Serum creatinine 
Liver function test 
OGCT and OGTT (24-28 weeks) 
(75 gm oral  glucose) 
 
Mode of delivery  
Term/preterm : 
Spontaneous/induced : 
Labournaturals /Outlet Forceps/ Vacuum/ Cesarean 
Complications during labour : 
Maternal injury : Yes/ No 
Shoulder Dystocia : Yes/No 
PPH : Yes/No     If yes, Medically managed / Surgically managed : 
Postnatal period : 
Difficulty in Lactation : Yes/No 
 
 
 
 
  
If cesarean-elective/emergency 
Indication for caesarean : 
Type of incision : Pfannensteil/RPM/others 
Closed with drain/not : 
 
Postoperative period  
Wound infection : Yes/No 
If yes , Pus culture : 
Thromboprophylaxis : Yes / No 
Respiratory infection : Yes / No 
Other complications if any : 
 
Baby details  
Term/preterm : 
Alive/deadborn/stillbirth 
Sex : Male / Female 
Birth weight : 
Apgar 1min : 5min : 
Admission in NICU : Yes/No 
If yes, reason and outcome : 
Congenital anomalies : Yes/No 
Type of anomaly : 
Postnatal follow–up : 
 
 
 
 
 
 
 
 
 
 
 
 
  
INFORMATION SHEET 
 We are conducting a study on the impact of BMI on perinatal and 
pregnancy outcome 
 We are selecting antenatal women according to the need for the study. We 
wish that you participate in this study. 
 Your participation in this study will not affect your AN care or any 
treatment if needed .  
 The privacy of the patients in the research will be maintained throughout 
the study.  
 In the event of any publication or presentation resulting from the research, 
no personally identifiable information will be shared. 
  Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or withdraw at any time; your decision will not 
result in any loss of benefits to which you are otherwise entitled.  
 The results of the study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in 
the management or treatment. 
 
 
Signature of the Investigator    Signature of the 
Participant 
Date: 
 
 
  
CONSENT FORM 
STUDY TITLE : HIGH QUETELET’S BODY MASS INDEX 
AND ITS EFFECT IN PREGNANCY: 
MATERNAL AND FETAL OUTCOME 
STUDY CENTRE : DEPARTMENT OF OBSTETRICS AND 
GYNECOLOGY, MADRAS MEDICAL 
COLLEGE, CHENNAI 
PARTICIPANT NAME:     AGE:                 MRD NO: 
I confirm that I have understood the purpose of procedure for the above study, I 
have the opportunity to ask the question and all my questions and doubts have 
been answered to my satisfaction. 
I have been explained about the possible complications that may occur during the 
procedure. I understand that my participation in the study in voluntary and that I 
am free to withdraw at any time without giving any reason. 
I understand that investigator, regulatory authorities and the ethics committee 
will not need my permission to look at my health records both in respect to the 
current study and any further research that may be conducted in relation to it, 
even if I withdraw from the study. I understand that my identity will not be 
revealed in any information released to third parties of published, unless as 
required under the law. I agree not to restrict the use of any or results that arise 
from the study. 
I hereby consent to participate in this study of “HIGH QUETELET’S BODY 
MASS INDEX AND ITS EFFECT IN PREGNANCY: MATERNAL AND 
FETAL OUTCOME”. 
 
 
 
Signature of Investigator :      Place : Chennai 
Signature / Thumb Impression of patient :                                     Date 
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Anemia  
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Post partum haemorrhage  
Caeserian delivery 
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Lactational dysfunction. 
Wound gaping 
Intra uterine growth retardation  
Preterm birth 
Oligohydramnios 
Instrumental delivery 
Pyrexia 
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49 Bhavani 22 20.03                      
50 Nandhini 20 24.05                      
51 Vaiseli 20 20.81                      
52 Pavithra 24 24.14                      
53 Ayesha 20 21.68                      
54 Muniyamma 20 22.31                      
55 Bakiyalakshmi 25 21.91                      
56 Abirami 20 22.94                      
57 Priya 18 23.44                      
58 Shabni 23 22.72                      
59 Shakile 26 23.78                      
60 Reetha 22 20.78                      
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61 Valli 30 24.11                      
62 Amudha 37 20.45                      
63 Kalaiyarasi 25 24.14                      
64 Sindhuja 23 24.41                      
65 Jenifer 24 23.11                      
66 Soundari 25 21.93                      
67 Keerthana 25 22.64                      
68 Lakshmi 22 22.03                      
69 Saradha 23 20.03                      
70 Suganya 24 24.52                      
71 Kuttiyammal 21 24.14                      
72 Revathy 20 24.39                      
73 Megeshwari 23 24.22                      
74 Shanmuga 19 22.03                      
75 Preethi 25 23.50                      
76 Banumathi 27 21.08                      
77 Nadhya 28 21.91                      
78 Lalitha 22 24.46                      
79 Aruna 24 21.01                      
80 Selvi 21 23.01                      
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81 Sridevi 38 22.31                      
82 Mahalakshmi 28 20.81                      
83 Parimala 27 22.94                      
84 Leelevathy 29 23.81                      
85 Kamatchi 29 22.06                      
86 Akila 23 24.89                      
87 Shanthi 31 23.07                      
88 Satya 25 23.61                      
89 Priya 30 23.15                      
90 Lavanya 20 23.11                      
91 Nagarani 30 23.92                      
92 Jansi 24 23.44                      
93 Divya 26 21.94                      
94 Vinitha 20 24.24                      
95 Sumaya 20 24.78                      
96 Lakshmi 30 20.83                      
97 Gomathy 23 23.83                      
98 Valli 30 23.63                      
99 Sumathy 28 23.05                      
100 Sonia 22 23.01                      
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101 Angelin 27 22.64                      
102 Narmadha 26 24.20                      
103 Nandhini 24 23.28                      
104 Chithra 25 19.42                      
105 Sameera 29 24.14                      
106 Meena 21 22.60                      
107 Sumithra 29 21.51                      
108 Mahalakshmi 26 20.24                      
109 Nandhini 25 23.44                      
110 Revathy 23 19.90                      
111 Asira Bee 19 22.94                      
112 Kavitha 24 21.86                      
113 Lalitha 28 24.76                      
114 Kalaiyarasi 25 22.07                      
115 Sumathy 23 23.73                      
116 Hemavathy 34 23.56                      
117 Vaishalini 21 24.98                      
118 Nancy 25 23.83                      
119 Nandhini 25 22.89                      
120 Selvi 26 23.15                      
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121 Yasrrin 21 21.25                      
122 Analorpavam 31 22.01                      
123 Prameela 21 21.36                      
124 Saranya 24 19.48                      
125 Pramila 21 24.44                      
126 Sowmya 20 24.54                      
127 Arokyasasi 30 22.83                      
128 Harini 21 21.05                      
129 Revathy 25 24.52                      
130 Uma 24 24.77                      
131 Matha Devi 25 24.11                      
132 Priyadharshin 20 21.36                      
133 Gayathri 24 24.17                      
134 Nagapriya 26 22.46                      
135 Narmedha 23 21.34                      
136 Sabiya Begam 22 21.93                      
137 Nandhini 23 23.65                      
138 Anandhi 26 24.91                      
139 Kamzhandai 27 21.33                      
140 Yasmeer 22 23.42                      
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141 Iswarya 21 20.81                      
142 Valermethy 23 21.64                      
143 Maheshwarn 24 24.91                      
144 Rashiya Banu 24 21.93                      
145 Nandhini 22 21.21                      
146 Pushpa 25 24.84                      
147 Saraswathy 23 21.48                      
148 Nandhini 25 21.23                      
149 Roja 20 20.44                      
150 Nandhini 23 21.78                      
151 Meera Devi 30 24.44                      
152 Sandhiya 20 22.81                      
153 Iswarya 21 22.77                      
154 Lakshmi 22 24.34                      
155 Meenakshi 28 24.88                      
156 Chithra 29 24.14                      
157 Jainap 25 23.12                      
158 Sumithra 19 21.46                      
159 sasi Rekha 27 23.78                      
160 Kalpana 28 24.89                      
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161 Devaki 21 23.83                      
162 Priya 19 22.94                      
163 Usha Rani 26 24.44                      
164 Varsha 20 24.65                      
165 Janani 25 22.86                      
166 Bhavani 21 22.89                      
167 Devi 29 23.61                      
168 Sangeetha 24 24.69                      
169 Vijayeshwari 22 20.45                      
170 Nithya 21 24.65                      
171 Janaki 18 20.83                      
172 Vinshiya 27 19.3                      
173 Padma 20 23.45                      
174 Yasmin 24 21.72                      
175 Muniammel 26 21.94                      
176 Kalpana 19 20.40                      
177 Abitha 26 22.37                      
178 Jamuna Rani 32 24.23                      
179 Deepika 24 23.42                      
180 Nirmala 25 23.44                      
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182 Vijayalakshmi 23 24.69                      
182 Meheshwari 20 20.27                      
183 Vinotha 28 20.40                      
184 Ruth 27 24.44                      
185 Jega Jothy 24 22.35                      
186 Sandhya 28 20.28                      
187 Sangeetha 22 19.63                      
188 Hemalatha 24 24.24                      
189 Dhanalakshm 20 19.56                      
190 Thameena 19 23.35                      
191 Kamatchi 23 19.57                      
192 Tharani 25 22.55                      
193 Thenmozhi 24 21.5                      
194 Shalini 23 23.4                      
195 Sowmya 19 22.5                      
196 Anbuselvi 23 21.9                      
197 Caroline 24 20.6                      
198 Pradeepa 22 22.7                      
199 Nandhini 27 23.3                      
200 Ashwini 25 22.6                      
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1 Sricithra 22 28.1                      
2 Siva Ranjini 26 26.22                      
3 Bhavani 29 25.28                      
4 Viji Priya 22 36.44                      
5 Padmashree 25 34.70                      
6 Anitha Shalini 27 35.25                      
7 Vanitha 27 39.96                      
8 Gayathri 31 38.52                      
9 Umma Salma 34 31.62                      
10 Gajalakshmi 37 35.94                      
11 Kanaga 28 36.68                      
12 Sharmila 27 34.67                      
13 Paramashwari 28 40.89                      
14 Mangalalaks 32 26.58                      
15 Nirmala 31 33.33                      
16 Nandhini 26 30.42                      
17 Saranya 18 27.26                      
18 Jothi 28 34.23                      
19 Fathima 29 33.78                      
20 Savitha 27 30.70                      
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21 Manju Baskar 33 34.17                      
22 Sudandra 30 28.89                      
23 Baby 28 26.28                      
24 Sabeera 27 27.04                      
25 Janath Banu 21 28.5                      
26 Shanthi 24 28.6                      
27 Shiny 26 30.11                      
28 Radhika 22 28.3                      
29 Chithradevi 22 26.94                      
30 Kalaivani 23 27.11                      
31 Mubeena 24 31.7                      
32 Ikaya Rani 27 27.56                      
33 Kalaiyarasi 29 27.7                      
34 Uma 21 27.58                      
35 Kerthika 23 25.97                      
36 Deepa 19 27.47                      
37 Bagyalakshmi 25 25.39                      
38 Banupriya 24 30.67                      
39 Menaga 23 29.7                      
40 Rohini 22 29.43                      
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41 Gayathri 20 25.71                      
42 Vinodhini 23 26.3                      
43 Kousalya 21 28.13                      
44 Girija 24 28.44                      
45 Mahalakshmi 32 26.16                      
46 Dilshad 24 26.11                      
47 Kumudavalli 20 26.64                      
48 Shaik Rihane 20 27.34                      
49 Pavithra 21 29.76                      
50 Prabavathy 20 25.45                      
51 Renjitha 20 25.58                      
52 Mala 24 25.56                      
53 Nithya 23 29.43                      
54 Pavithra 24 26.22                      
55 Anthonyma 23 30.1                      
56 Sasikala 22 32.39                      
57 Barkari 24 29.72                      
58 Sangeetha 27 30.48                      
59 Tamilselvi 24 28.19                      
60 Jeevitha 27 26.03                      
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61 Sivaranjini 23 31.23                      
62 Muthu Priya 24 28.04                      
63 Vijitha 28 29.16                      
64 Sasikala 22 25.96                      
65 Clara 28 27.73                      
66 Kowsalya 22 25.3                      
67 Aishwarya 24 29.42                      
68 Remya 27 30.44                      
69 Vidhya 25 29.14                      
70 Geetha 23 27.41                      
71 Shanbagavalli 24 27.01                      
72 Eldammel 20 25.97                      
73 Rekha 27 27.69                      
74 Selvi 32 28.30                      
75 Deepa 27 28.15                      
76 Manjula 30 35.02                      
77 Reena 27 32.28                      
78 Bhavani 24 34.70                      
79 Chandra 30 31.47                      
80 Madhana 29 29.97                      
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81 Kareema 29 28.40                      
82 Sarala 25 30.13                      
83 Sharmila 25 36.73                      
84 Aruna 22 35.03                      
85 Punithvathi 40 32.32                      
86 Shanthakumar 29 34.81                      
87 Padmavathy 27 28,93                      
88 Ranjitha 19 26.67                      
89 Kavitha 22 29.17                      
90 Kanagalakshm 29 30.61                      
91 Sruthi 23 26.16                      
92 Rajeshwari 24 28.45                      
93 Sowmya 22 25.20                      
94 Sharmila 23 25.85                      
95 Selvasani 22 28.89                      
96 Manju 23 26.49                      
97 Arul mozhi 24 28.83                      
98 Kalaivani 27 27.95                      
99 Kowsalya 26 28.57                      
100 Vijayalakshmi 24 28.04                      
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101 Shaima 24 29.43                      
102 Sainash 21 33.56                      
103 Sivagami 22 30.86                      
104 Vinela 30 28.54                      
105 Nagavalli 24 27.93                      
106 Navasiya 30 30.82                      
107 Durga Devi 26 27.77                      
108 Yeseemani 31 27.93                      
109 Divya 24 32.84                      
110 Mahalakshmi 26 29.28                      
111 Subitha 21 36.16                      
112 Maninozhi 27 27.77                      
113 Kaviya Shree 20 31.64                      
114 Revathi 31 29.16                      
115 Chithra 29 27.06                      
116 Mohana 29 26.04                      
117 Meenakshi 28 27.83                      
118 Mariya 26 27.56                      
119 Subashini 22 26.3                      
120 Praveena 27 31.62                      
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121 Sathya 37 26.20                      
122 Sagundala 35 28.13                      
123 Shamila 25 28.76                      
124 Kalaivani 26 30.08                      
125 Sumaya 27 27.05                      
126 Tamilmozhi 25 25.78                      
127 Varalakshmi 23 26.90                      
128 Sherin 27 28.65                      
129 Kavitha 22 28.57                      
130 Deepa 19 29.35                      
131 Mala 26 27.04                      
132 Shanthi 28 27.41                      
133 Kasthuri 31 26.74                      
134 Devi 25 25.88                      
135 Nalini 22 32.89                      
136 Rahima 25 29.04                      
137 Kalaiarasi 24 26.67                      
138 Kumudha 19 25.56                      
139 Clarit Emelda 23 28.94                      
140 Chithra 23 32.84                      
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141 Thaseen  26 29.27                      
142 Fathima 29 28.15                      
143 Dhivya 27 27.53                      
144 Madhusri 21 27.34                      
145 Jayarshre 24 27.43                      
146 Kalavathy 25 28.15                      
147 Kanchana 22 27.94                      
148 Deepthika 25 27.34                      
149 Sameemurish 27 26.22                      
150 Maareshwari 27 26.78                      
151 Gayathri 24 26.44                      
152 Umasalma 24 27.41                      
153 Yasmin 28 27.56                      
154 Nivetha 21 31.63                      
155 Maniregale 22 28.93                      
156 Remya 27 32.05                      
157 Nandhini 26 25.72                      
158 Revathy 22 39.11                      
159 Vasanthi 25 26.13                      
160 Sravanthi 24 25.78                      
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161 Sabeera 27 27.24                      
162 Nelathi 22 28.04                      
163 Archana 24 37.84                      
164 Sudandra 30 26.67                      
165 Gajalakshmi 27 26.56                      
166 Sandhya 24 25.33                      
167 Lavanya 22 25.33                      
168 Malathy 28 27.59                      
169 Revathi 23 26.57                      
170 Revathy 26 32.05                      
171 Radhika 24 30.02                      
172 Bhavani 30 26.16                      
173 Kalpana 27 28.62                      
174 Kalaselvi 30 25.68                      
175 Muthupriya 25 27.59                      
176 Rubini 26 28.67                      
177 Bhuvaneshwa 22 28.91                      
178 Gayathri 28 27.27                      
179 Anandhi 28 30.86                      
180 Jayanthi 24 27.77                      
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181 Asha 31 32.46                      
182 Sangeetha 32 30.22                      
183 Agalya 22 30.26                      
184 Sudha 31 32.04                      
185 Arnula 32 26.44                      
186 Nishathi  29 26.67                      
187 Punitha 30 25.08                      
188 Ashwini 25 28.87                      
189 Sunitha 19 26.7                      
190 Saranya 24 30.02                      
191 Praveena 22 29.80                      
192 Nandhini 27 27.08                      
193 Suganya 20 26.58                      
194 Malar 23 29.42                      
195 Arulmozhi 21 32.05                      
196 Jeyanthi 19 25.84                      
197 Rita 26 29.76                      
198 Mythili 24 27.04                      
199 Priyanka 22 30.68                      
200 Reshma 
 
21 27.96                      
 
